ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 90,300
+1,500 (1.69%)
Oct 10, 2025, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 1.87 trillion as of October 10, 2025. Its market cap has decreased by -11.45% in one year.
Market Cap
1.87T
Enterprise Value
1.90T
Revenue
298.11B
Ranking
n/a
PE Ratio
53.54
Stock Price
90,300.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 1.87T, an increase of 107.19%. That is a compound annual growth rate of 8.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 1,837.92B | 2.68% |
| Dec 30, 2024 | 1,790.03B | 40.37% |
| Dec 28, 2023 | 1,275.23B | -22.60% |
| Dec 29, 2022 | 1,647.65B | -36.55% |
| Dec 30, 2021 | 2,596.92B | 34.10% |
| Dec 30, 2020 | 1,936.49B | 248.32% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |